Expression of acid-sensing ion channel 1 in papillary thyroid carcinoma and metastatic lesions
Open Access
- 14 November 2026
- journal article
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 22 (7) , 755-759
Abstract
Background. Acid-sensing ion channel 1 (ASIC1) is a proton-gated cation channel encoded by the ASIC1 gene, one of five paralogous genes that form trimeric acid-sensing ion channels in mammals. An acidic extracellular microenvironment is a hallmark of solid tumors. ASIC1 is activated by extracellular acidification and functions as a key sensor of tumor acidosis. Increasing evidence indicates that ASIC1 contributes to multiple aspects of tumor biology, including cancer cell proliferation, migration, invasion, and metastatic dissemination. Aberrant ASIC1 expression has been reported in several malignancies, including hepatocellular, breast, gastric, brain and other cancers, suggesting that this ion channel may represent a novel biomarker and therapeutic target. The purpose was to investigate ASIC1 expression in conditionally normal thyroid tissue, primary papillary thyroid carcinoma (PTC), and metastatic lesions, and to evaluate its association with metastatic progression. Materials and methods. Postoperative samples of tissue were obtained from the surgical department of the clinic. The amount of ASIC1 was determined using enzyme immunoassay kits. Results. ASIC1 expression was significantly higher in primary PTC tissue without metastases than in adjacent conditionally normal tissue. Furthermore, tumors with lymph node metastases exhibited significantly greater ASIC1 expression than non-metastatic PTCs. The highest ASIC1 expression levels were detected in recurrent metastatic lesions, indicating a progressive increase in expression during tumor dissemination and recurrence. Conclusions. Elevated ASIC1 expression is associated with papillary thyroid carcinoma progression and metastatic potential. These findings suggest that ASIC1 may serve as a promising diagnostic biomarker for PTC and a potential predictor of metastatic spread, particularly recurrent metastasis. Further studies are warranted to clarify the mechanistic role of ASIC1 in thyroid cancer progression and to assess its value as a therapeutic target.This publication has 19 references indexed in Scilit:
- Acid-sensing ion channels and downstream signalling in cancer cells: is there a mechanistic link?Pflügers Archiv - European Journal of Physiology, 2024
- Acid-sensing ion channel 1: potential therapeutic target for tumorBiomedicine & Pharmacotherapy, 2022
- ASIC1a stimulates the resistance of human hepatocellular carcinoma by promoting EMT via the AKT/GSK3β/Snail pathway driven by TGFβ/Smad signalsJournal of Cellular and Molecular Medicine, 2022
- Involvement of acid-sensing ion channel 1a in gastric carcinoma cell migration and invasionActa Biochimica et Biophysica Sinica, 2018
- Glioblastoma cancer stem cell lines express functional acid sensing ion channels ASIC1a and ASIC3Scientific Reports, 2017
- ASIC1 and ASIC3 contribute to acidity-induced EMT of pancreatic cancer through activating Ca2+/RhoA pathwayCell Death & Disease, 2017
- ASIC and ENaC type sodium channels: conformational states and the structures of the ion selectivity filtersThe FEBS Journal, 2016
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2016
- Regulation of breast tumorigenesis through acid sensorsOncogene, 2015
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976